Welcome to ATMP Sweden!
ATMP Sweden is the national network of Sweden’s activities within medicines based on genes, cells or tissue engineering, classified as Advanced Therapy Medicinal Products (ATMPs) in Europe. Our goal is to promote the collaboration and communication needed for accelerated, effective ATMP based patient solutions.
News
2022-11-06
hPSC-ATMP, Sweden and beyond
Tillväxtverket pilot study for hPSC derived cell therapies Innovation catalyst
Read article
2022-09-13
Ny rapport ger vägledning kring samverkan mellan patienter, vård och forskning
Varför ska vi samverka mellan intressenter med olika kompetenser, erfarenheter och förutsättningar?
Read article
2022-08-23
Synergy in cell therapy development through mutual respect
The Novo Nordisk/Karolinska Institutet/St Erik/Vecura model
Read article
Download "Regulatory lessons COVID19 vaccines for gene therapy"
At ATMP Sweden 2021 Axel Ståhlbom summarised regulatory learnings from the approval of COVID19 vaccines and how this is relevant to the gene therapy/GTMP field. Download the slides on our ’What are ATMPs’ page!
Resources
Learn more about the Health Technology Assessment related issues of your ATMP development.
This guide will provide useful information and insights throughout the ATMP development process.
Find or advertise ATMP relevant job opportunities.
Conferences & events
Conference
Lund Stem Cell Center | 20th Anniversary Conference
17 April
AF-Borgen Sandgatan 2, Lund
Organizer: Lund Stem Cell Center
We invite you to join us in celebrating 20 years of excellence within stem cell research and regenerative medicine!
Read more